how does a glp 1 agonist work glp-1_analogs [TUSOM Evolution of GLP‐1 Receptor Agonists

Description

[DOI] [PMC free article] [PubMed] [Google Scholar] 799.Nagell C.F., Wettergren A., Orskov C., Holst J.J

Glucagon agonism in the treatment of metabolic diseases including type 2 diabetes mellitus and obesity

GLP-1 receptor agonists may reduce risk for obesity-related cancers among people with diabetes compared with dipeptidyl peptidase-4 inhibitors, according to findings scheduled for presentation at ASCO Annual Meeting

The two primary endpoints were the Kansas City Cardiomyopathy Questionnaire clinical summary score (KCCQ-CSS, which ranges from 0 to 100) and the Kansas City Cardiomyopathy Questionnaire Clinical Summary Score (KCCQ-CSS)